Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Overview of attention for article published in Clinical Infectious Diseases, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
twitter: 9 X users

patent: 4 patents
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 125 Dimensions

Readers on

mendeley: 131 Mendeley

Summary News X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 30,773 followers.

#In #ClinInfectDis Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. https://t.co/B3eRwzlKTx

23 Feb 2018

Reply Repost Favourite

RT @drbrainbugz: A TLR9 agonist increases HIV transcription while enhancing cytotoxic NK cells-potential eradication therapy: https://t.co/…

05 Oct 2017

Reply Repost Favourite

RT @drbrainbugz: A TLR9 agonist increases HIV transcription while enhancing cytotoxic NK cells-potential eradication therapy: https://t.co/…

05 Oct 2017

Reply Repost Favourite

A TLR9 agonist increases HIV transcription while enhancing cytotoxic NK cells-potential eradication therapy: https://t.co/7lnbPFyCOm

05 Oct 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.